Your browser doesn't support javascript.
loading
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
Stuart, Arabella S V; Virta, Miia; Williams, Kristi; Seppa, Ilkka; Hartvickson, Robyn; Greenland, Melanie; Omoruyi, Edmund; Bastian, Arangassery Rosemary; Haazen, Wouter; Salisch, Nadine; Gymnopoulou, Efi; Callendret, Benoit; Faust, Saul N; Snape, Matthew D; Heijnen, Esther.
  • Stuart ASV; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
  • Virta M; Tampere University, Tampere, Finland.
  • Williams K; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.
  • Seppa I; Tampere University, Tampere, Finland.
  • Hartvickson R; Axtell Clinic, Newton, Kansas, USA.
  • Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
  • Omoruyi E; Janssen Infectious Diseases, Beerse, Belgium.
  • Bastian AR; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.
  • Haazen W; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.
  • Salisch N; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.
  • Gymnopoulou E; Janssen Infectious Diseases, Beerse, Belgium.
  • Callendret B; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.
  • Faust SN; NIHR Southampton Clinical Research Facility and NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Snape MD; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
  • Heijnen E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
J Infect Dis ; 227(1): 71-82, 2022 12 28.
Article en En | MEDLINE | ID: mdl-36259542
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Adult / Child / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Adult / Child / Humans Idioma: En Año: 2022 Tipo del documento: Article